Metformin, a widely used antidiabetic drug, has shown geroprotective potential by activating AMPK and inhibiting mTOR, thereby improving mitochondrial function and reducing inflammation and insulin resistance—key features of metabolic aging (45, 46). The gene discussed is MTOR; the disease is Insulin resistance.